What is Solasta Bio?
Solasta Bio is at the forefront of developing novel, highly selective, and environmentally conscious insect control agents. The company's innovative approach centers on the creation of short peptides designed to disrupt essential functions within pest species, while crucially sparing beneficial insects and vertebrates. This targeted methodology ensures high selectivity, minimal environmental impact, and low residue profiles, positioning Solasta Bio as a key player in modern pest management strategies and the broader biotechnology sector.
How much funding has Solasta Bio raised?
Solasta Bio has raised a total of $19M across 2 funding rounds:
Other Financing Round
$5M
Series A
$14M
Other Financing Round (2023): $5M with participation from Yield Lab Europe, Scottish Enterprise, Cavallo Ventures, Rubio Impact Ventures, and SIS Ventures
Series A (2024): $14M led by Forbion
Key Investors in Solasta Bio
Forbion
Forbion is a global life sciences venture capital firm that invests across multiple fund strategies covering all stages of pharmaceutical drug development, with a primary focus on innovative therapeutics companies in Europe and North America. They also invest in sustainable solutions across food, agriculture, materials, and environmental technologies.
Scottish Enterprise
Scottish Enterprise is a national economic development agency and a non-departmental public body of the Scottish Government, focused on driving economic growth and innovation within Scotland.
Cavallo Ventures
Cavallo Ventures is the venture capital arm of Wilbur Ellis, focused on introducing innovative technologies across all business divisions and markets globally, providing capital and deep expertise, particularly in agriculture and novel ingredients.
What's next for Solasta Bio?
The recent major strategic investment into Solasta Bio, following its Series A financing, indicates strong investor confidence and a clear trajectory towards commercialization and market expansion. This capital infusion is expected to accelerate the development and deployment of its peptide-based pest control solutions. The company's focus on sustainable and selective agents aligns with growing global demand for eco-friendly agricultural and public health solutions, suggesting a robust future for Solasta Bio as it navigates its enterprise-level growth phase.
See full Solasta Bio company page
